1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 13 Hits
  • 検索条件 : 絞込み (MeSH = Adenocarcinoma, Clear Cell / genetics*)
生物種 リソース名 タイトル
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-9(RCB2226) MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
ヒト・動物細胞 JHOC-5(RCB1520) A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
ヒト・動物細胞 TUHR4TKB(RCB1198) , TUHR10TKB(RCB1275) , TUHR14TKB(RCB1383) Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
ヒト・動物細胞 JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
ヒト・動物細胞 JHOC-5(RCB1520) PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
ヒト・動物細胞 JHOC-5(RCB1520) ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-9(RCB2226) MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
ヒト・動物細胞 Epigenetic determinants of ovarian clear cell carcinoma biology.
ヒト・動物細胞 JHOC-9(RCB2226) , JHOC-5(RCB1520) Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
ヒト・動物細胞 JHOC-9(RCB2226) Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
ヒト・動物細胞 NIH:OVCAR-3(RCB2135) Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma.
ヒト・動物細胞 OS-RC-2(RCB0735) Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.